A model for crowdsourcing high-impact research questions for Castleman disease and other rare diseases

[1]  Ania Korsunska,et al.  Research Agenda-Setting in Medicine: Shifting from a Research-Centric to a Patient-Centric Approach , 2021, iConference.

[2]  E. Jaffe,et al.  ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare Disorder , 2020, Cell reports. Medicine.

[3]  R. Francis,et al.  Rare musculoskeletal diseases in adults: a research priority setting partnership with the James Lind Alliance , 2020, Orphanet Journal of Rare Diseases.

[4]  Tudor I. Oprea,et al.  How many rare diseases are there? , 2019, Nature Reviews Drug Discovery.

[5]  Barry Bayus,et al.  Crowdsourcing in medical research: concepts and applications , 2019, PeerJ.

[6]  Mary Zuccato,et al.  The Collaborative Network Approach: a model for advancing patient-centric research for Castleman disease and other rare diseases. , 2019, Emerging topics in life sciences.

[7]  Anne R. Pariser,et al.  From scientific discovery to treatments for rare diseases – the view from the National Center for Advancing Translational Sciences – Office of Rare Diseases Research , 2018, Orphanet Journal of Rare Diseases.

[8]  A. Barnett,et al.  What incentives increase data sharing in health and medical research? A systematic review , 2017, Research integrity and peer review.

[9]  Matthew A Cooper,et al.  Institutional profile: Community for Open Antimicrobial Drug Discovery – crowdsourcing new antibiotics and antifungals , 2017, Future science OA.

[10]  Daniel L. Shaw.  Is Open Science the Future of Drug Development? , 2017, The Yale journal of biology and medicine.

[11]  L. Davis,et al.  Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis , 2016, Lupus.

[12]  John P. A. Ioannidis,et al.  Why Most Clinical Research Is Not Useful , 2016, PLoS medicine.

[13]  P. Phillips.  The research pipeline , 2014 .

[14]  Published Online.  Biomedical research: increasing value, reducing waste , 2014 .

[15]  Jeremy N. Burrows,et al.  The Open Access Malaria Box: A Drug Discovery Catalyst for Neglected Diseases , 2013, PloS one.

[16]  Zachary F. Meisel,et al.  Crowdsourcing—Harnessing the Masses to Advance Health and Medicine, a Systematic Review , 2013, Journal of General Internal Medicine.

[17]  P. Glasziou,et al.  Avoidable waste in the production and reporting of research evidence , 2009, The Lancet.

[18]  N. Powe,et al.  The relation between funding by the National Institutes of Health and the burden of disease. , 1999, The New England journal of medicine.